15.62 USD
-0.32 (-2.01%)
Last: Feb 9, 2026, 02:45 PM
Taking everything into account, NRC scores 4 out of 10 in our fundamental rating. NRC was compared to 102 industry peers in the Health Care Providers & Services industry. While NRC has a great profitability rating, there are quite some concerns on its financial health. NRC has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year NRC was profitable.
- NRC had a positive operating cash flow in the past year.
- In the past 5 years NRC has always been profitable.
- In the past 5 years NRC always reported a positive cash flow from operatings.
1.2 Ratios
- NRC's Return On Assets of 12.06% is amongst the best of the industry. NRC outperforms 97.06% of its industry peers.
- NRC has a Return On Equity of 114.31%. This is amongst the best in the industry. NRC outperforms 99.02% of its industry peers.
- NRC has a better Return On Invested Capital (21.73%) than 97.06% of its industry peers.
- NRC had an Average Return On Invested Capital over the past 3 years of 37.15%. This is significantly above the industry average of 9.16%.
- The 3 year average ROIC (37.15%) for NRC is well above the current ROIC(21.73%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.06% | ||
| ROE | 114.31% | ||
| ROIC | 21.73% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
1.3 Margins
- The Profit Margin of NRC (11.76%) is better than 97.06% of its industry peers.
- NRC's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 19.80%, NRC belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
- NRC's Operating Margin has declined in the last couple of years.
- NRC has a better Gross Margin (62.05%) than 82.35% of its industry peers.
- NRC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% |
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NRC is creating value.
- Compared to 1 year ago, NRC has less shares outstanding
- NRC has less shares outstanding than it did 5 years ago.
- NRC has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 3.16 indicates that NRC is not in any danger for bankruptcy at the moment.
- NRC has a Altman-Z score of 3.16. This is in the better half of the industry: NRC outperforms 66.67% of its industry peers.
- The Debt to FCF ratio of NRC is 6.31, which is on the high side as it means it would take NRC, 6.31 years of fcf income to pay off all of its debts.
- NRC has a Debt to FCF ratio (6.31) which is in line with its industry peers.
- NRC has a Debt/Equity ratio of 5.31. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 5.31, NRC is not doing good in the industry: 78.43% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.31 | ||
| Debt/FCF | 6.31 | ||
| Altman-Z | 3.16 |
ROIC/WACC2.51
WACC8.65%
2.3 Liquidity
- A Current Ratio of 0.53 indicates that NRC may have some problems paying its short term obligations.
- NRC's Current ratio of 0.53 is on the low side compared to the rest of the industry. NRC is outperformed by 85.29% of its industry peers.
- NRC has a Quick Ratio of 0.53. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
- NRC has a worse Quick ratio (0.53) than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
- The earnings per share for NRC have decreased by -1.19% in the last year.
- NRC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.24% yearly.
- Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -1.99% in the last year.
- Measured over the past years, NRC shows a small growth in Revenue. The Revenue has been growing by 4.42% on average per year.
EPS 1Y (TTM)-1.19%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%N/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 12.50 indicates a correct valuation of NRC.
- Compared to the rest of the industry, the Price/Earnings ratio of NRC indicates a rather cheap valuation: NRC is cheaper than 85.29% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of NRC to the average of the S&P500 Index (27.93), we can say NRC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, NRC is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
- The rest of the industry has a similar Price/Free Cash Flow ratio as NRC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.9 | ||
| EV/EBITDA | 12.71 |
4.3 Compensation for Growth
- The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.86
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- NRC has a Yearly Dividend Yield of 4.02%, which is a nice return.
- NRC's Dividend Yield is rather good when compared to the industry average which is at 0.47. NRC pays more dividend than 99.02% of the companies in the same industry.
- NRC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.02% |
5.2 History
- The dividend of NRC decreases each year by -17.40%.
- NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 65.02% of the earnings are spent on dividend by NRC. This is not a sustainable payout ratio.
DP65.02%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:NRC (2/9/2026, 2:45:38 PM)
15.62
-0.32 (-2.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-03 2026-02-03/bmo
Earnings (Next)04-27 2026-04-27
Inst Owners49.6%
Inst Owner Change-2.01%
Ins Owners10.45%
Ins Owner Change2.71%
Market Cap353.95M
Revenue(TTM)148.58M
Net Income(TTM)16.36M
Analysts45
Price TargetN/A
Short Float %3.27%
Short Ratio4.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.02% |
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP65.02%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.5 | ||
| Fwd PE | N/A | ||
| P/S | 2.54 | ||
| P/FCF | 27.9 | ||
| P/OCF | 13.47 | ||
| P/B | 24.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.71 |
EPS(TTM)1.25
EY8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.56
FCFY3.58%
OCF(TTM)1.16
OCFY7.42%
SpS6.14
BVpS0.63
TBVpS-2.39
PEG (NY)N/A
PEG (5Y)3.86
Graham Number4.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.06% | ||
| ROE | 114.31% | ||
| ROCE | 28.35% | ||
| ROIC | 21.73% | ||
| ROICexc | 22.24% | ||
| ROICexgc | 79.8% | ||
| OM | 19.8% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% | ||
| FCFM | 9.12% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score6
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.31 | ||
| Debt/FCF | 6.31 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 194.38% | ||
| Cap/Sales | 9.77% | ||
| Interest Coverage | 7.13 | ||
| Cash Conversion | 76.08% | ||
| Profit Quality | 77.53% | ||
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 3.16 |
F-Score6
WACC8.65%
ROIC/WACC2.51
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.08%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.24%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-23.9%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%
NATIONAL RESEARCH CORP / NRC FAQ
What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NRC.
Can you provide the valuation status for NATIONAL RESEARCH CORP?
ChartMill assigns a valuation rating of 4 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Fairly Valued.
What is the profitability of NRC stock?
NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.
What are the PE and PB ratios of NATIONAL RESEARCH CORP (NRC) stock?
The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 12.5 and the Price/Book (PB) ratio is 24.73.
Can you provide the financial health for NRC stock?
The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.